BARICICH, Alessio
 Distribuzione geografica
Continente #
EU - Europa 3.332
NA - Nord America 2.630
AS - Asia 1.909
SA - Sud America 389
AF - Africa 109
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.382
Nazione #
US - Stati Uniti d'America 2.516
IE - Irlanda 824
IT - Italia 608
SG - Singapore 605
HK - Hong Kong 393
DE - Germania 383
SE - Svezia 375
FR - Francia 328
CN - Cina 313
BR - Brasile 290
UA - Ucraina 237
RU - Federazione Russa 204
VN - Vietnam 182
FI - Finlandia 113
IN - India 100
GB - Regno Unito 90
CA - Canada 83
KR - Corea 63
IR - Iran 47
ID - Indonesia 42
BJ - Benin 41
AR - Argentina 37
JP - Giappone 35
BD - Bangladesh 25
BE - Belgio 24
MX - Messico 24
NL - Olanda 24
ZA - Sudafrica 24
CZ - Repubblica Ceca 23
EG - Egitto 21
ES - Italia 21
TR - Turchia 21
AT - Austria 17
EC - Ecuador 17
PL - Polonia 17
PE - Perù 13
MY - Malesia 12
PK - Pakistan 12
AU - Australia 11
PY - Paraguay 10
CL - Cile 9
LT - Lituania 9
PH - Filippine 8
TW - Taiwan 8
RS - Serbia 7
TH - Thailandia 7
NG - Nigeria 6
SA - Arabia Saudita 6
CH - Svizzera 5
IQ - Iraq 5
VE - Venezuela 5
BG - Bulgaria 4
CO - Colombia 4
JO - Giordania 4
KE - Kenya 4
MO - Macao, regione amministrativa speciale della Cina 4
DZ - Algeria 3
GR - Grecia 3
MA - Marocco 3
MK - Macedonia 3
NP - Nepal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
EU - Europa 2
KH - Cambogia 2
KZ - Kazakistan 2
LI - Liechtenstein 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
LV - Lettonia 1
MT - Malta 1
MV - Maldive 1
NO - Norvegia 1
PR - Porto Rico 1
SR - Suriname 1
VC - Saint Vincent e Grenadine 1
Totale 8.382
Città #
Dublin 817
Jacksonville 392
Hong Kong 377
Singapore 242
Beijing 170
Dearborn 168
Ashburn 164
Chandler 161
Wilmington 117
Princeton 99
Lawrence 98
Los Angeles 97
Ann Arbor 87
Piemonte 70
San Mateo 67
Moscow 66
Buffalo 59
Ho Chi Minh City 52
Seoul 52
Novara 47
Munich 43
Cotonou 41
Helsinki 41
Turin 41
New York 39
Milan 37
São Paulo 34
Hanoi 32
Andover 31
Boardman 31
Dong Ket 30
Montreal 30
Bremen 27
Vercelli 26
Dallas 25
Frankfurt am Main 25
Rome 25
Brussels 24
Chennai 24
Nuremberg 24
Jakarta 23
Redondo Beach 23
Poplar 22
Brno 21
Johannesburg 20
Toronto 18
London 16
Stockholm 16
Falkenstein 15
Houston 15
Nanjing 15
Tokyo 15
Denver 14
Warsaw 13
Zanjan 13
Orem 12
Vienna 12
Woodbridge 12
Turku 11
Amsterdam 10
Ankara 10
Atlanta 10
Fairfield 10
Kunming 10
Mexico City 10
Monza 10
Al Maḩallah al Kubrá 9
Hefei 9
Seattle 9
Tianjin 9
Alessandria 8
Boston 8
Chicago 8
Mumbai 8
Norwalk 8
Phoenix 8
Santa Clara 8
Tehran 8
Bangkok 7
Bari 7
Cairo 7
Curitiba 7
Haiphong 7
Monmouth Junction 7
Ottawa 7
Sham Shui Po 7
Strasbourg 7
Villa Cortese 7
Belo Horizonte 6
Brooklyn 6
Dhaka 6
Leawood 6
Lima 6
Manchester 6
Melbourne 6
Porto Alegre 6
Quito 6
Rio de Janeiro 6
Shenyang 6
West Jordan 6
Totale 4.650
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 330
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 205
Clinical and instrumental evaluation of Botulinum Toxin type A safety profile in post stroke spasticity rehabilitation treatment 185
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 149
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 138
Sarcopenic dysphagia: a narrative review 121
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 120
Buccal hemineglect: is it useful to evaluate the differences between the two halves of the oral cavity for the multidisciplinary rehabilitative management of right brain stroke survivors? A cross-sectional study 115
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. 111
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 111
RIEDUCAZIONE DEL CAMMINO NEL MORBO DI PARKINSON: TRATTAMENTO ROBOTIZZATO VERSUS TRAINING SU TREADMILL. STUDIO RANDOMIZZATO CONTROLLATO 108
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 107
Effects of Denosumab on Bone Turnover Markers compared to Zoledronic Acid in severe osteoporotic women: a randomized head to head study 103
A Rare Cause of Back Pain During Pregnancy and Lactation: Management and Treatment 103
Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies 103
Adjuvant treatments associated with botulinum toxin injection for managing spasticity: An overview of the literature 101
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 95
ONCE YEARLY ZOLEDRONIC ACID AFTER 18 MONTHS OF PARATHYROID HORMONE (1-84) FOR SEVERE OSTEOPOROSIS 93
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 92
Accurate gait analysis in post-stroke patients using a single inertial measurement unit 92
Heart Rate Variability modifications induced by high doses of incobotulinumtoxinA and onabotulinumtoxinA in hemiplegic chronic stroke patients: A single blind randomized controlled, crossover pilot study 90
MULTIMODAL ANALGESIA AND REHABILITATION PROTOCOL IN TOTAL KNEE REPLACEMENT: A PILOT STUDY 89
Can scoliosis lead to spinal cord ischaemia? Early diagnosis and rehabilitation: A paradigmatic case report and literature review 88
Abobotulinumtoxina and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis 87
Chronic stroke: an oxymoron or a challenge for rehabilitation? 84
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 82
Clinical characteristics that impact onabotulinumtoxinA treatment adherence in patients with spasticity from ASPIRE 80
Peripheral facial nerve palsy: how effective is rehabilitation? 79
Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients 79
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 79
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review 79
Administration of type a botulinum toxin after total hip replacement 78
Risk factors and outcome in falls 74
Long-term effects of intra-articular oxygen-ozone therapy versus hyaluronic acid in older people affected by knee osteoarthritis: A randomized single-blind extension study 74
Development of a patient-centered questionnaire for post-stroke spasticity assessment: a reliability study 74
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from the ASPIRE Study 74
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN POST-STROKE PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 74
A single-blinded,randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot 73
The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study 72
Efficacy of a Hip Flexion Assist Orthosis in Adults With Hemiparesis After Stroke. 72
Evaluation of the safety profile of intra-articular treatment with Oxygen-Ozone therapy in knee arthrosis: controlled randomized study 71
Once Yearly Zoledronic Acid After 18 months of Parathyroid Hormone (1-84) for Severe Osteoporosis 70
Efficacy and safety of a hip flexion assist orthosis in adult hemiplegic stroke patients 70
La valutazione dell’outcome nel percorso riabilitativo della protesi di ginocchio 70
Confronto randomizzato, controllato in doppio cieco tra casting e taping nel trattamento riabilitativo dopo tossina botulinica A 70
The value of adding mirror therapy for upper limb motor recovery of subacute stroke patients: a randomized controlled trial. 69
People with Spinal Cord Injury in Italy 69
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 69
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach 69
Heart rate variability (hrv) modifications in adult hemiplegic patients after botulinum toxin type a (nt-201) injection. 68
Sonographic and clinical effects of botulinum toxin Type A combined with extracorporeal shock wave therapy on spastic muscles of children with cerebral palsy 68
Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study 68
Robotic gait training is not superior to conventional treadmill training in parkinson disease: a single-blind randomized controlled trial. 68
Low back pain related to a sacral insufficiency fracture: Role of paravertebral oxygen-ozone therapy in a paradigmatic case of nociplastic pain 68
Adherence to onabotulinumtoxina treatment in multiple sclerosis patients with spasticity from the aspire study 68
What is the impact of robotic rehabilitation on balance and gait outcomes in people with multiple sclerosis? A systematic review of randomized control trials 67
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 66
Once yearly Zoledronic Acid in Osteoporotic PD Patients compared to agematched osteoporotic post menopausal women 66
From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients 65
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 64
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke 64
ADHERENCE TO ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH SPASTICITY FROM THE ASPIRE STUDY 64
A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature 63
Indicatori di qualità per la continuità delle cure in Medicina Riabilitativa 63
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 63
Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect 63
Balance Rehabilitation through Robot-Assisted Gait Training in Post-Stroke Patients: A Systematic Review and Meta-Analysis 62
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study 62
Optimization of transdisciplinary management of elderly with femur proximal extremity fracture: A patient-tailored plan from orthopaedics to rehabilitation 62
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study 61
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study 60
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation 60
ABOBOTULINUMTOXINA AND REHABILITATION VERSUS REHABILITATION ALONE IN POSTSTROKE SPASTICITY: AN ITALIAN COST-UTILITY ANALYSIS 59
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation 59
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 58
Development of new biomarkers in the prevention of lymphedema related to breast cancer: a multidisciplinary challenge 58
Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients 58
Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis 56
Tolerability, Safety and Efficacy of a Specific Rehabilitation Treatment Protocol for Axillary Web Syndrome: An Observational Retrospective Study 56
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects 55
Does altering inclination alter effectiveness of treadmill training for gait impairment after stroke? A randomized controlled trial. 55
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study 55
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE 55
Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment 54
Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials 54
High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis 53
Valutazione comparativa di tre diversi protocolli riabilitativi post-inoculo di tossina botulinica A sull’ipertono spastico dell’arto inferiore 52
The past and future of Functional Neurology 52
Post-stroke spasticity as a condition: A new perspective on patient evaluation 52
Management of spasticity with onabotulinumtoxinA: Practical guidance based on the Italian real-life post-stroke spasticity survey 52
Transcranial Direct Current Stimulation Combined with Botulinum Neurotoxin Type A Injections for Treatment of Upper Limb Intention Tremor in Multiple Sclerosis: A Case Report 52
Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study 51
Management of stroke patients submitted to botulinum toxin type a therapy: A Delphi survey of an Italian expert panel of specialist injectors 51
Ultrasound-guided injection of botulinum toxin type a for piriformis muscle syndrome: A case report and review of the literature 51
Differentiation among bio- and augmented- feedback in technologically assisted rehabilitation 51
Effects of robot-assisted gait training on postural instability in parkinson's disease: A systematic review 51
The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A 50
Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study 49
Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE 49
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity 47
Totale 7.768
Categoria #
all - tutte 53.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.211


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021400 0 0 0 0 0 23 90 14 80 46 98 49
2021/2022905 41 13 148 67 57 54 52 52 62 61 119 179
2022/20231.644 129 79 74 35 91 147 52 87 810 18 68 54
2023/2024833 61 48 49 27 105 29 150 62 19 61 75 147
2024/20251.538 49 24 68 32 55 163 181 151 359 122 67 267
2025/20261.958 209 186 351 686 444 82 0 0 0 0 0 0
Totale 8.597